Â鶹ŮÓÅ

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • Â鶹ŮÓÅ Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Medicaid Work Mandate
  • Suicide Prevention
  • Community Health Workers
  • Rural Health Payout
  • Opioid Crisis

TRENDING TOPICS:

  • Medicaid Work Mandate
  • Suicide Prevention
  • Community Health Workers
  • Rural Health Payout
  • Opioid Crisis

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Dec 22 2023

Full Issue

Viewpoints: How Was Phenylephrine Approved Despite Being Ineffective?; Confusion On Supervised Drug Sites

Editorial writers discuss OTC decongestants, supervised drug sites, abortion and more.

In 2005, federal law compelled retailers nationwide to move pseudoephedrine, sold as Sudafed, from over-the-counter (OTC) to behind it, so as to combat its use in making illicit methamphetamine. This move changed the formulas of cough and cold medicines in the U.S.. It also led me and my colleague Leslie Hendeles to prove that pseudoephedrine’s replacement, oral phenylephrine, was ineffective as a decongestant. (Randy Hatton, 12/21)

It’s been two years since New York City became home to the nation’s first legally sanctioned supervised consumption program, where people can take illicit drugs like heroin, crack and methamphetamine under medical supervision. By many accounts that program is thriving. More than 1,000 potentially fatal overdoses have been reversed and many people who use the facilities have been connected to support services, including addiction treatment. (Jeneen Interlandi, 12/22)

In 2022, the court took away the constitutional right to abortion by overturning Roe vs. Wade and created a chaotic patchwork of abortion access in this country. Now the issues before the court involve the most commonly used abortion method — medication abortion with the drug mifepristone — and whether the U.S. Food and Drug Administration has final authority to make its own rules and regulations governing drugs. (12/22)

Much of the country no doubt watched in amazement last week as a woman with a doomed pregnancy was forced to flee her home state, Texas, to get the abortion her doctors deemed necessary to protect her future ability to bear children. Could this really be happening in the United States in 2023? (Linda Greenhouse, 12/22)

In the days leading up to Christmas in the pediatric intensive care unit (PICU), medical teams work to send as many children home as they can. Kids should be with their people for the holidays. And it makes sense. But for parents of children receiving in-home care — parents like me — it can be a relief to surrender to the hospital’s siren song. For families like mine, the PICU can be a respite, especially during Christmas. (Maria Kefalas, 12/22)

The current AI frenzy is focused on generative AI technologies like ChatGPT, DALL-E, and Gemini that create original writing, images, computer code, and even music. In medicine, people are throwing GPT at every problem under the sun, testing it as a scribe that can help doctors complete medical records, a chatbot that can offer public health advice, and a tool to diagnose patients and recommend treatment. (Archana Venkataraman, 12/21)

As 2023 comes to an end, I want to highlight five hopeful health stories that I’ve had the privilege to report on this year. (Leana S. Wen, 12/21)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 Â鶹ŮÓÅ